Thanks to TAG's board, staff, and generous donors. This work would not be possible without your support.
Treatment Action Group is an independent AIDS research and policy think tank fighting for better treatment, a vaccine, and a cure for AIDS. TAG works to ensure that all people with HIV receive lifesaving treatment, care, and information.
We are science-based treatment activists working to expand and accelerate vital research and effective community engagement with research and policy institutions.
TAG catalyzes open collective action by all affected communities, scientists, and policy makers to end AIDS.
Funds for this project were provided by the New York City Council (contract number 81620070016282).
This publication was written and compiled by Simon Collins (HIV i-Base, UK) and Tracy Swan (Treatment Action Group, US). Additional editorial comments are included from: Sanjay Bhagani, M.D., Polly Clayden, Jen Curry, Marc Ennals, Ramon Espacio, Loon Gangte, Charles Gore, Camilla Graham, M.D., Mauro Guarinieri, Kelly Safreed Harmon, Bob Huff, Marianna Iwulska, Robert James, Maxime Journiac, Svilen Konov, Luis Mendão, Silvia Petretti, David Pieper, Jack Summerside, Joan Tallada, Carmen Tarrades, and Kate Thomson.
Illustrator: Lei Chou
Designer: Adam Fredericks
Copy Editor: Andrea Benzacar Dailey
Disclaimer: Information in this booklet is not intended to replace information from your doctor or other healthcare providers. Decisions related to your treatment should be made in consultation with your doctor.
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.
|A Review of Late-Stage HIV Antiretroviral Candidates at IDWeek 2017|
|'Caring at Its Essence': HIV Nurses Recall Pivotal Moments With Patients|
|PrEP Prescriptions Rise Sharply, but Unequally, in New York City|
|How to Reverse Implicit Bias in HIV Care: 6 Steps to Take Today|
|In Their Words: Burdens of HIV Nursing Include Lack of Respect and Resources|
|Conversations With Federal HIV Leaders From the 2017 U.S. Conference on AIDS|